Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of SARS-CoV-2
ANN ARBOR, Mich., Jan. 27, 2021 /PRNewswire/ — Swift Biosciences of Ann Arbor, MI has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers. The Swift Normalase® Amplicon SARS-CoV-2 S Gene Panel (SNAP) eliminates the need to perform qPCR for library normalization. A pioneer in the development of DNA and RNA library... Read more